GSK 224876 T27442
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
GSK 224876 is a novel next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI). It has activity against efavirenz-resistant strains in the treatment of treatment-naive HIV-1-infected subjects.
CAS nr:
1097733-15-7
Purity:
98%
Molecular Weight:
413,79
SMILES:
Cc1cc(cc(c1)[P@](=O)(c2c3cc(ccc3[nH]c2C(=O)N)Cl)OC)/C=C/C#N
Formula:
C20H17ClN3O3P
Pathway:
Target:
